| SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ... Nature 599 (7883), 114-119, 2021 | 1201 | 2021 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 916 | 2021 |
| Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ... Nature 603 (7902), 706-714, 2022 | 868 | 2022 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 695 | 2021 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 424 | 2021 |
| Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70 SA Kemp, B Meng, IA Ferriera, R Datir, WT Harvey, G Papa, S Lytras, ... BioRxiv, 2020.12. 14.422555, 2020 | 245 | 2020 |
| Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation SA Kemp, DA Collier, R Datir, IATM Ferreira, S Gayed, A Jahun, ... MedRxiv, 2020 | 183 | 2020 |
| SARS-CoV-2 B. 1.617 mutations L452R and E484Q are not synergistic for antibody evasion IATM Ferreira, SA Kemp, R Datir, A Saito, B Meng, P Rakshit, ... The Journal of infectious diseases 224 (6), 989-994, 2021 | 147 | 2021 |
| SARS-CoV-2 B. 1.617. 2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough P Mlcochova, S Kemp, MS Dhar, G Papa, B Meng, S Mishra, C Whittaker, ... | 141* | 2021 |
| COVID-19 Genomics UK (COG-UK) Consortium SA Kemp, DA Collier, RP Datir, I Ferreira, S Gayed, A Jahun, M Hosmillo, ... Sharrocks K, Blane E, Modis Y, Leigh KE, Briggs JAG, van Gils MJ, Smith KGC …, 2021 | 102 | 2021 |
| SARS-CoV-2 B. 1.617 emergence and sensitivity to vaccine-elicited antibodies I Ferreira, R Datir, G Papa, S Kemp, B Meng, P Rakshit, S Singh, ... BioRxiv, 2021 | 96 | 2021 |
| Indian SARS-CoV-2 Genomics Consortium (INSACOG); Genotype to Phenotype Japan (G2P-Japan) Consortium; CITIID-NIHR BioResource COVID-19 Collaboration. SARS-CoV-2 B. 1.617. 2 … P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, I Ferreira, R Datir, ... Nature 599 (7883), 114-9, 2021 | 86 | 2021 |
| COVID-19 Genomics UK (COG-UK) Consortium Sensitivity of SARS-CoV-2 b. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, I Ferreira, B Meng, RP Datir, AC Walls, SA Kemp, ... Nature 593 (7857), 136-141, 2021 | 65 | 2021 |
| Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase MJ Siedner, MA Moorhouse, B Simmons, T de Oliveira, R Lessells, ... Nature communications 11 (1), 5922, 2020 | 63 | 2020 |
| SARS-CoV-2 B. 1.1. 7 escape from mRNA vaccine-elicited neutralizing antibodies R Gupta, D Collier, A De Marco, I Ferreira, B Meng, R Datir, A Walls, ... | 46 | 2021 |
| SARS-CoV-2 Omicron spike mediated immune escape and tropism shift B Meng, IATM Ferreira, A Abdullahi, N Goonawardane, A Saito, I Kimura, ... BioRxiv, 2021.12. 17.473248, 2021 | 35 | 2021 |
| COVID-19 Genomics UK (COG-UK) Consortium B Meng, SA Kemp, G Papa, R Datir, I Ferreira, S Marelli, WT Harvey, ... Recurrent emergence of SARS-CoV-2 spike deletion H 69, 109-292, 2021 | 32 | 2021 |
| A cross-sectional survey of the knowledge, attitudes, and practices of antimicrobial users and providers in an area of high-density livestock-human population in Western Kenya SA Kemp, GL Pinchbeck, EM Fèvre, NJ Williams Frontiers in veterinary science 8, 727365, 2021 | 29 | 2021 |
| High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment K El Bouzidi, SA Kemp, RP Datir, F Murtala-Ibrahim, A Aliyu, V Kwaghe, ... Journal of Antimicrobial Chemotherapy 75 (6), 1575-1579, 2020 | 22 | 2020 |
| SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa A Abdullahi, D Oladele, M Owusu, SA Kemp, J Ayorinde, A Salako, D Fink, ... Nature communications 13 (1), 6131, 2022 | 18 | 2022 |
Ravindra Kumar GuptaUniversity of CambridgeVerified email at cam.ac.uk
